Abstract
Foods and beverages containing live microbes (probiotics) are increasingly promoted by health professionals nowadays. The probiotic products in the market are mostly milk-based products, for instance yoghurts. There has been a high demand for the non-dairy probiotic products from those having the lactose intolerance problem and/or worry about the high cholesterol content. Therefore, fruit is now becoming the preferable matrix for probiotic delivery in human body. Fruits could be another promising carrier for probiotic strains, particularly from the genera of Lactobacilli and Bifidobacteria. Somehow, the cell viability and stability are highly fruit and strain dependent, in addition to the processing factors and storage temperature. In the present review, fruits, particularly pomegranate is critically highlighted as a potential fruity vehicle for probiotic microbiota. Pomegranate contains bioactive secondary metabolites (anthocyanins, ellagic acid derivatives and hydrolyzable tannins) and non-digestible carbohydrates (prebiotics). The low pH value of pomegranate juice could be compromised by mixing with other fruits or by protecting probiotics from acidic environment by microencapsulation. This review covers the previous works which were carried out on the fruit-based probiotic foods and beverages, supported by the mechanistic explanation on the action of probiotics in human body.
Keywords: Probiotic foods, prebiotic, pomegranate, fruit juice, Lactobacillus, Bifidobacterium, microencapsulation, ellagitannins.
Graphical Abstract
Current Nutrition & Food Science
Title:A Review on Fruit Juice Probiotication: Pomegranate
Volume: 12 Issue: 1
Author(s): Siti M. Mustafa, Lee S. Chua, Hesham A. El- Enshasy, Fadzilah A. A. Majid and Roslinda A. Malek
Affiliation:
Keywords: Probiotic foods, prebiotic, pomegranate, fruit juice, Lactobacillus, Bifidobacterium, microencapsulation, ellagitannins.
Abstract: Foods and beverages containing live microbes (probiotics) are increasingly promoted by health professionals nowadays. The probiotic products in the market are mostly milk-based products, for instance yoghurts. There has been a high demand for the non-dairy probiotic products from those having the lactose intolerance problem and/or worry about the high cholesterol content. Therefore, fruit is now becoming the preferable matrix for probiotic delivery in human body. Fruits could be another promising carrier for probiotic strains, particularly from the genera of Lactobacilli and Bifidobacteria. Somehow, the cell viability and stability are highly fruit and strain dependent, in addition to the processing factors and storage temperature. In the present review, fruits, particularly pomegranate is critically highlighted as a potential fruity vehicle for probiotic microbiota. Pomegranate contains bioactive secondary metabolites (anthocyanins, ellagic acid derivatives and hydrolyzable tannins) and non-digestible carbohydrates (prebiotics). The low pH value of pomegranate juice could be compromised by mixing with other fruits or by protecting probiotics from acidic environment by microencapsulation. This review covers the previous works which were carried out on the fruit-based probiotic foods and beverages, supported by the mechanistic explanation on the action of probiotics in human body.
Export Options
About this article
Cite this article as:
Mustafa M. Siti, Chua S. Lee, El- Enshasy A. Hesham, Majid A. A. Fadzilah and Malek A. Roslinda, A Review on Fruit Juice Probiotication: Pomegranate, Current Nutrition & Food Science 2016; 12 (1) . https://dx.doi.org/10.2174/1573401311666151015213508
DOI https://dx.doi.org/10.2174/1573401311666151015213508 |
Print ISSN 1573-4013 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3881 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Artificial Intelligence, Big Data and Machine Learning Approaches in Precision Medicine & Drug Discovery
Current Drug Targets Glutathione-Triggered Drug Release from Nanostructures
Current Topics in Medicinal Chemistry Breast Cancer: Current Molecular Therapeutic Targets and New Players
Anti-Cancer Agents in Medicinal Chemistry Cerenkov Luminescence Imaging at a Glance
Current Molecular Imaging (Discontinued) New Emerging Trends in Protein and Peptide Based Therapeutic Approaches – Part I
Current Protein & Peptide Science The Role of Stress Proteins in Prostate Cancer
Current Genomics DNA Microarray-Based Gene Expression Profiling in Cancer: Aiding Cancer Diagnosis, Assessing Prognosis and Predicting Response to Therapy
Current Pharmacogenomics DephosSitePred: A High Accuracy Predictor for Protein Dephosphorylation Sites
Combinatorial Chemistry & High Throughput Screening In Silico Studies in Drug Research Against Neurodegenerative Diseases
Current Neuropharmacology Computational Methods and Algorithms for Mass-Spectrometry Based Differential Proteomics
Current Proteomics Assessing Activation States in Microglia
CNS & Neurological Disorders - Drug Targets Liposomes and Lipid Envelope-Type Systems for Systemic siRNA Delivery
Current Pharmaceutical Design Mucosal Healing in Crohn’s Disease: Relevance for Clinical Outcomes
Current Drug Targets New Features in the Treatment of Androgen-Independent Prostate Cancer
Current Pharmaceutical Design Drug-Induced Peripheral Neuropathy: Diagnosis and Management
Current Cancer Drug Targets Advances in Photodynamic Therapy of Cancer
Current Cancer Therapy Reviews Small Peptide and Protein-based Molecular Probes for Imaging Neurological Diseases
Current Protein & Peptide Science Arsenic-exposed Keratinocytes Exhibit Differential microRNAs Expression Profile; Potential Implication of miR-21, miR-200a and miR-141 in Melanoma Pathway
Clinical Cancer Drugs Upregulation of Focal Adhesion Kinase by 14-3-3ε via NFκB Activation in Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review
Current Pharmaceutical Design